As drug-related deaths continue to rise across the UK, the government has launched a new nationwide consultation aimed at expanding access to naloxone, a life-saving medication that can reverse opioid overdoses. The move forms part of a wider £3.4 billion investment in drug and alcohol services over the next three years, described as the largest funding commitment of its kind in recent history.
At Chijos News, we closely follow policies that affect vulnerable communities, including migrants, rough sleepers and marginalised groups across the UK. For many in the Nigerian diaspora and other immigrant communities, issues such as homelessness, mental health, addiction and access to healthcare often sit quietly in the background, rarely discussed but deeply impactful.
The 10-week consultation, launched on 29 December 2025, seeks public and professional input on how naloxone can be made more widely available to those most at risk of opioid overdose. Government figures show drug-related deaths have doubled since 2012, with a record 5,448 lives lost in England and Wales last year alone. Particularly alarming is the sharp rise in deaths linked to nitazenes, a powerful synthetic opioid, which increased from 52 cases in 2023 to 180 in 2024.
Naloxone is a medication that temporarily reverses the effects of an opioid overdose, buying crucial time until emergency medical help arrives. It cannot be misused and has no effect if opioids are not present, making it a safe emergency intervention. Yet despite previous regulatory changes, access remains uneven and limited by stigma, lack of awareness and operational barriers.
Minister of State for Health Karin Smyth described every drug-related death as a preventable tragedy, stressing that naloxone can be the difference between life and death. She said the government wants to remove barriers that stop naloxone reaching people at the critical moment when their life is on the line, whether through frontline workers or members of the public responding to an emergency.
Under the new proposals, the government is consulting on changes that would allow naloxone to be supplied directly to homeless hostels, outreach services and day centres working with people sleeping rough. The plans would also enable emergency staff at organisations such as Border Force, the National Crime Agency and laboratory testing facilities to carry naloxone, particularly when they may encounter dangerous synthetic opioids during their work. Another proposal would introduce publicly accessible naloxone emergency boxes in high-risk areas, similar to defibrillator cabinets, including busy high streets and nightlife zones.
Although naloxone is currently classified as a prescription-only medicine, legislation introduced in December 2024 expanded who can supply it without a prescription, including police officers, paramedics and probation workers. The government now wants to go further, working alongside local authorities and charities to widen access even more.
Homelessness charities have welcomed the move. Sean Palmer, Executive Director of Strategy and Transformation at St Mungo’s, said wider access to naloxone would be a vital step in supporting people experiencing homelessness who are also using opioids. He noted that outreach teams regularly carry naloxone and frequently save lives, adding that substance use is often linked to complex trauma, mental health challenges and a lack of stable housing.
The consultation builds on earlier reforms that contributed to the government’s ambition to prevent nearly 1,000 drug-related deaths in England by the end of 2025. Officials say the new proposals aim to address remaining gaps, particularly around public awareness and practical access.
Alongside expanding naloxone access, the government says it remains committed to prevention. In October 2025, it launched a campaign warning young people about the risks of ketamine, counterfeit medicines, synthetic opioids and THC vapes, following a rise in drug-related harm among those aged 16 to 24. Schools, universities and local public health teams have since been given additional resources to help young people make informed choices.
This latest consultation is being conducted jointly with the Department of Health in Northern Ireland and has the backing of all four UK nations, following agreement that wider naloxone access should be a national priority. Subject to consultation responses and parliamentary approval, the government aims to introduce the new legislative changes in 2026 through amendments to the Human Medicines Regulations 2012.
For communities across the UK, including many migrants and diaspora families who may be quietly affected by addiction, housing insecurity or mental health struggles, these changes could mean more lives saved and more second chances. Naloxone does not solve the root causes of drug misuse, but it provides something equally important: time, hope and the opportunity for recovery.
Support and information on drug-related issues is available via the national service Talk to Frank.
